RAMJA’s AMR Panel delivers rapid detection of critical antimicrobial resistance genes directly from clinical samples. Ideal for early therapy guidance, outbreak control, and infection prevention protocols.
The rise of antimicrobial resistance is a global health emergency. RAMJA’s rapid AMR panel equips clinicians with actionable gene-level results in under 90 minutes, helping ensure proper antibiotic use and reduce the spread of resistant infections.
Identifies resistance genes in under 90 minutes for timely treatment decisions.
Includes carbapenemases (NDM, KPC, OXA), ESBLs (CTX-M, TEM), and MRSA/VRE markers.
Processes blood, urine, swab, sputum, and wound fluid.
Useful in ICU, NICU, sepsis management, and outbreak surveillance.
F-89/7, 2nd Floor UNIT NO-2, Pocket F,
Okhla Phase I, Okhla Industrial Estate,
New Delhi, Delhi 110020
011 4446 9753